VSJ-110 for Dry Eye

Recruiting at 4 trial locations

Overseen By Vanda Pharmaceuticals

Age: 18+

Sex: Any

Trial Phase: Phase 2

Sponsor: Vanda Pharmaceuticals

Must not be taking: Disallowed medications

Disqualifiers: Others

Prior Safety Data This treatment has passed at least one previous human trial

Compensation: Varies

Number of Visits: Unknown

Duration: 8 weeks

160 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.

Are You a Good Fit for This Trial?

This trial is for adults over 18 who have dry eye syndrome. Participants must be able to follow instructions, attend all study visits, and sign consent forms. They cannot use certain medications during the study.

Inclusion Criteria

Provide written informed consent and sign the HIPAA form

Be willing and able to follow all instructions and attend all study visits

I am 18 years old or older.

Exclusion Criteria

I am not taking any medications that are not allowed in the study.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive VSJ-110 or placebo for the treatment of dry eye

8 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• VSJ-110

Trial Overview The trial is testing VSJ-110 against a placebo to see if it's safe and effective in treating dry eye. It lasts eight weeks, with patients randomly receiving either the actual drug or a placebo.

How Is the Trial Designed?

Group I: VSJ-110 Solution Experimental Treatment 1 Intervention

Group II: Placebo Solution Placebo Group 1 Intervention

Who Is Running the Clinical Trial?

Vanda Pharmaceuticals

Lead Sponsor

Trials

68

Recruited

19,900+